Elkaeed, E.B.; Khalifa, M.M.; Alsfouk, B.A.; Alsfouk, A.A.; El-Attar, A.-A.M.M.; Eissa, I.H.; Metwaly, A.M.
The Discovery of Potential SARS-CoV-2 Natural Inhibitors among 4924 African Metabolites Targeting the Papain-like Protease: A Multi-Phase In Silico Approach. Metabolites 2022, 12, 1122.
https://doi.org/10.3390/metabo12111122
AMA Style
Elkaeed EB, Khalifa MM, Alsfouk BA, Alsfouk AA, El-Attar A-AMM, Eissa IH, Metwaly AM.
The Discovery of Potential SARS-CoV-2 Natural Inhibitors among 4924 African Metabolites Targeting the Papain-like Protease: A Multi-Phase In Silico Approach. Metabolites. 2022; 12(11):1122.
https://doi.org/10.3390/metabo12111122
Chicago/Turabian Style
Elkaeed, Eslam B., Mohamed M. Khalifa, Bshra A. Alsfouk, Aisha A. Alsfouk, Abdul-Aziz M. M. El-Attar, Ibrahim H. Eissa, and Ahmed M. Metwaly.
2022. "The Discovery of Potential SARS-CoV-2 Natural Inhibitors among 4924 African Metabolites Targeting the Papain-like Protease: A Multi-Phase In Silico Approach" Metabolites 12, no. 11: 1122.
https://doi.org/10.3390/metabo12111122
APA Style
Elkaeed, E. B., Khalifa, M. M., Alsfouk, B. A., Alsfouk, A. A., El-Attar, A.-A. M. M., Eissa, I. H., & Metwaly, A. M.
(2022). The Discovery of Potential SARS-CoV-2 Natural Inhibitors among 4924 African Metabolites Targeting the Papain-like Protease: A Multi-Phase In Silico Approach. Metabolites, 12(11), 1122.
https://doi.org/10.3390/metabo12111122